Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Prahl

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Medrxiv : the Preprint Server for Health Sciences|August 10, 2021
COVID-19 mRNA Vaccination in Lactation: Assessment of adverse events and vaccine related antibodies in mother-infant dyadsYarden Golan, Mary Prahl, Arianna G Cassidy, et al.
Malaria Journal|October 9, 2016
Timing of in utero malaria exposure influences fetal CD4 T cell regulatory versus effector differentiationMary Prahl, Prasanna Jagannathan, Tara I McIntyre, et al.
Frontiers in Immunology|November 22, 2021
COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant DyadsYarden Golan, Mary Prahl, Arianna G Cassidy, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancyMary Prahl, Yarden Golan, Arianna G Cassidy, et al.
Nature Communications|July 30, 2022
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancyMary Prahl, Yarden Golan, Arianna G Cassidy, et al.
Research Square|December 21, 2021
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancyMary Prahl, Yarden Golan, Arianna G Cassidy, et al.
Plos Medicine|July 18, 2018
Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trialPrasanna Jagannathan, Abel Kakuru, Jaffer Okiring, et al.
Science Translational Medicine|January 13, 2022
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudovirusesBenjamin L Sievers, Saborni Chakraborty, Yong Xue, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: Prospective cohort studyDongli Song, Mary Prahl, Stephanie L Gaw, et al.
BMJ Open|July 8, 2021
Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort studyDongli Song, Mary Prahl, Stephanie L Gaw, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Medrxiv : the Preprint Server for Health Sciences|August 10, 2021
COVID-19 mRNA Vaccination in Lactation: Assessment of adverse events and vaccine related antibodies in mother-infant dyadsYarden Golan, Mary Prahl, Arianna G Cassidy, et al.
Malaria Journal|October 9, 2016
Timing of in utero malaria exposure influences fetal CD4 T cell regulatory versus effector differentiationMary Prahl, Prasanna Jagannathan, Tara I McIntyre, et al.
Frontiers in Immunology|November 22, 2021
COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant DyadsYarden Golan, Mary Prahl, Arianna G Cassidy, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancyMary Prahl, Yarden Golan, Arianna G Cassidy, et al.
Nature Communications|July 30, 2022
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancyMary Prahl, Yarden Golan, Arianna G Cassidy, et al.
Research Square|December 21, 2021
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancyMary Prahl, Yarden Golan, Arianna G Cassidy, et al.
Plos Medicine|July 18, 2018
Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trialPrasanna Jagannathan, Abel Kakuru, Jaffer Okiring, et al.
Science Translational Medicine|January 13, 2022
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudovirusesBenjamin L Sievers, Saborni Chakraborty, Yong Xue, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: Prospective cohort studyDongli Song, Mary Prahl, Stephanie L Gaw, et al.
BMJ Open|July 8, 2021
Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort studyDongli Song, Mary Prahl, Stephanie L Gaw, et al.
Pageof 4